文献速递产科母胎医学

子痫前期后数年女性内皮功能下降且亚临床心力衰竭增加

Decreased endothelial function and increased subclinical heart failure in women several years after pre-eclampsia.
PubMed 文献 · Ultrasound Obstet Gynecol · 2018-06-19

该观察性研究纳入67例子痫前期后至少4年的女性及37例健康经产对照,采用超声评估心脏功能与几何形态,并测定肱动脉血流介导舒张(FMD)。子痫前期史组HF-B患病率25%高于对照8%(P<0.05),FMD 6.12%低于对照8.22%(P<0.01);校正代谢综合征危险因素及产科参数后,子痫前期史仍独立与较低FMD相关(β=-1.88;95%CI -3.59至-0.18),但HF-B与低FMD无关联。

要点

  • 子痫前期后至少4年女性HF-B患病率25%,高于健康经产对照8%(P<0.05)。
  • 子痫前期史组FMD 6.12%低于对照8.22%(P<0.01)。
  • 校正代谢综合征危险因素及产科参数后,子痫前期史仍独立与较低FMD相关(β=-1.88;95%CI -3.59至-0.18)。

核心结论

  • 子痫前期后数年女性FMD较低且HF-B更常见,但HF-B与FMD降低无关联。

研究设计与样本

  • 观察性研究纳入67例子痫前期后至少4年的女性及37例健康经产对照。
  • 采用超声评估心脏功能与几何形态,并测定肱动脉FMD评估内皮功能。
  • HF-B定义为左心室肥厚(左心室质量指数>95 g/m2)、向心性重构(相对室壁厚度>0.42且左心室质量指数≤95 g/m2)、轻度收缩功能障碍(左心室射血分数>40%且<55%)或无症状瓣膜病。
  • 采用logistic回归分析评估FMD与子痫前期、代谢综合征危险因素及产科参数的关联。

主要发现

  • 子痫前期史组HF-B患病率25% vs 对照8%(P<0.05),子痫前期史组较对照升高。
  • 子痫前期史组FMD 6.12% vs 对照8.22%(P<0.01),子痫前期史组较对照降低。
  • 校正代谢综合征危险因素及产科参数后,子痫前期史仍独立与较低FMD相关(β=-1.88;95%CI -3.59至-0.18)。
  • 在子痫前期史女性中,HF-B与低FMD无关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Pre-eclampsia (PE) is associated with both postpartum endothelial dysfunction and asymptomatic structural heart alterations consistent with heart failure Stage B (HF-B). In this study, we assessed the relationship between endothelial function, measured by flow-mediated dilation (FMD), and HF-B in women with a history of PE. METHODS: This was an observational study in which 67 formerly pre-eclamptic women (≥ 4 years postpartum) and 37 healthy parous controls were assessed ultrasonographically for cardiac function and geometry, as well as for endothelial function by means of brachial artery FMD. HF-B was diagnosed as left ventricular hypertrophy (left ventricular mass index (LVMi) > 95 g/m2 ), concentric remodeling (relative wall thickness > 0.42 and LVMi ≤ 95 g/m2 ), mild systolic dysfunction (left ventricular ejection fraction > 40% and < 55%) or asymptomatic valvular disease. Cardiovascular and metabolic syndrome variables were compared between women with history of PE and controls, as well as between those in the formerly pre-eclamptic group who had HF Stage A, HF-B or no HF. Logistic regression analysis was performed to assess the associations of FMD with PE, metabolic syndrome risk factors and obstetric parameters. RESULTS: The prevalence of HF-B amongst formerly pre-eclamptic women was three-fold higher than that observed for controls (25% vs 8%, P < 0.05), while FMD was lower in formerly pre-eclamptic women compared with controls (6.12% vs 8.22%, P < 0.01); history of PE remained associated independently with lower FMD after adjusting for metabolic syndrome risk factors and obstetric parameters (β, -1.88; 95% CI, -3.59 to -0.18). However, HF-B did not relate to low FMD in formerly pre-eclamptic women. CONCLUSIONS: Years after pregnancy, formerly pre- eclamptic women have lower FMD and have HF-B more often compared with healthy parous controls. Nonetheless, HF-B was not related to reduced FMD. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Breetveld NM, Ghossein-Doha C, van Neer J, et al. Decreased endothelial function and increased subclinical heart failure in women several years after pre-eclampsia. Ultrasound Obstet Gynecol. 2018. PMID: 28557250. doi:10.1002/uog.17534

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。